Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

The STIFLE Study

Trial categories: Breathing

Sponsoring organisation: AstraZeneca

Do you have Asthma?

A 24 week randomised exploratory open-label study aiming to characterise changes in airway inflammation, symptoms, lung function, and reliever use in asthma patients using SABA (Salbutamol) or anti-inflammatory reliever (Symbicort) as rescue medication in addition to Symbicort as daily asthma controller.

Investigating Asthma inflammation in patients taking daily Asthma medication.

Measurements will be performed daily by patients at home using devices which will connect to a Smartphone.

You could take part in the STIFLE Study if you:

  • are age 18 or over
  • have been diagnosed with Asthma for at least 6 months
  • can complete daily measurements at home for the next 6 months
  • have needed to use oral steroids for worsening asthma symptoms

For information, please contact:

01865 227 242 /